Astrana Health (ASTH) EBIT Margin (2016 - 2025)
Historic EBIT Margin for Astrana Health (ASTH) over the last 17 years, with Q3 2025 value amounting to 2.01%.
- Astrana Health's EBIT Margin fell 39300.0% to 2.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.1%, marking a year-over-year decrease of 28200.0%. This contributed to the annual value of 4.39% for FY2024, which is 17100.0% down from last year.
- According to the latest figures from Q3 2025, Astrana Health's EBIT Margin is 2.01%, which was down 39300.0% from 3.11% recorded in Q2 2025.
- In the past 5 years, Astrana Health's EBIT Margin registered a high of 23.41% during Q3 2021, and its lowest value of 1.1% during Q4 2023.
- In the last 5 years, Astrana Health's EBIT Margin had a median value of 6.18% in 2024 and averaged 7.22%.
- Data for Astrana Health's EBIT Margin shows a peak YoY increase of 97300bps (in 2021) and a maximum YoY decrease of -134800bps (in 2021) over the last 5 years.
- Over the past 5 years, Astrana Health's EBIT Margin (Quarter) stood at 1.15% in 2021, then soared by 271bps to 4.28% in 2022, then crashed by -126bps to 1.1% in 2023, then skyrocketed by 110bps to 0.11% in 2024, then soared by 1756bps to 2.01% in 2025.
- Its last three reported values are 2.01% in Q3 2025, 3.11% for Q2 2025, and 3.32% during Q1 2025.